Abstract
Microprocessor controlled transdermal delivery of anticancer drugs 5-Fluorouracil (5-FU) and 6-Mercaptopurine (6-MP) was developed and in vitro evaluation was done. Drugs were loaded based on the pharmacokinetics parameters. In vitro diffusion studies were carried at different current density (0.0, 0.1, 0.22, 0.50 mA/cm2). The patches were evaluated for the drug content, thickness, weight, folding endurance, flatness, thumb tack test and adhesive properties all were well with in the specification of transdermal patches with elegant and transparent in appearance. In vitro permeation studies through human cadaver skin showed, passive delivery (0.0 mA/cm2) of 6-MP was low. As the current density was progressively increased, the flux also increased. the flux also increased with 0.1 mA/cm2 for 15–20 min, but it was less than desired flux, 0.2 mA/cm2 for 30 min showed better flux than 0.1 mA/cm2 current, but lag time was more than 4 h, 0.5 mA/cm2 current for more than 1 h, flux was >159 µg/cm2 h which was desired flux for 6-MP. 5-FU flux reached the minimum effective concentration (MEC) of 54 μg/cm2 h with 0.5 mA/cm2 current for 30–45 min, drug concentration were within the therapeutic window in post-current phase. We concluded from Ohm’s Law that as the resistance decreases, current increases. Skin resistance decrease with increase in time and current, increase in the drug permeation. Interestingly, for all investigated current densities, as soon as the current was switched off, 5-FU and 6-MP flux decreased fairly, but the controlled drug delivery can be achieved by switching the current for required period of time.
Similar content being viewed by others
References
Y.W. Chein, Novel Drug Delivery Systems Revised and Expanded, 2nd edn. (Marcel Dekker Inc., New York, 2005), pp. 301–380
J.A. Subramony, A. Sharma, J.B. Phipps, Microprocessor controlled transdermal drug delivery. Int. J. Pharm. 317, 1–6 (2006). doi:10.1016/j.ijpharm.2006.03.053
E.R. Scott, J.B. Phipps, J.R. Gyory, R.V. Padmanabhan, Electrotransport systems for transdermal delivery. A practical implementation of iontophoresis, in Handbook of Pharmaceutical Controlled Release Technology, ed. by D.L. Wise (Marcel Dekker Inc., New York, 2005), pp. 617–657
C.T.S. Ching, I. Camilleri, P. Conoll, A low-cost programmable device for versatile current delivery in iontophoresis applications. Sens. Actuators 106, 534–540 (2005). doi:10.1016/j.snb.2004.07.022
W. Bleyer, Central nervous system leukemia. Pediatr. Clin. North Am. 35, 789–814 (1988)
B. Bostrom, G. Erdmann, Cellular pharmacology of 6-mercaptopurine in acute lymphoblastic leukemia. Am. J. Pediatr. Hematol. Oncol. 15, 80–86 (1993). doi:10.1097/00043426-199302000-00024
C. Cuffari, S. Hunt, T.M. Bayless, Enhanced bioavailability of azathioprine compared to 6-mercaptopurine therapy in inflammatory bowel disease: correlation with treatment efficacy. Alim. Pharmacol. Ther. 14, 1009–1014 (2000). doi:10.1046/j.1365-2036.2000.00812.x
J. Romagnuolo, D.C. Sadowski, E. Lalor, L. Jewell, A.B. Thomson, Cholestatic hepatocellular injury with azathioprine: a case report and review of the mechanisms of hepatotoxicity. Can. J. Gastroenterol. 12, 479–483 (1988)
J.M. Joulia, F. Pinguet, M. Ychou, J. Duffour, C. Astre, F. Bressolle, Plasma and salivary pharmacokinetics of 5-fluorouracil (5-FU) in patients with metastatic colorectal cancer receiving 5-FU bolus continuous infusion with high-dose folinic acid. Eur. J. Cancer 35, 296–301 (1999)
C. Zinutti, M. Barberi-Heyob, M. Hoffman, P. Maincent, In-vivo evaluation of sustained release microspheres of 5-FU in rabbits. Int. J. Pharm. 166, 231–234 (1998)
R.B. Diasio, B.E. Harris, Clinical pharmacology of 5-fluorouracil. Clin. Pharmacokinet. 16, 215–237 (1989)
N.S. Chandrashekar, R.H. Shobha Rani, Cytotoxicity, anti-tumor activity, cumulative skin irritation and sensitization study of 5-fluorouracil from a transdermal patch for Dalton’s lymphoma ascites cells. J. Health Sci. 53, 275–281 (2007)
A.M. Kligman, E. Christopher, Preparation of isolated sheets of human stratum corneum. Arch. Dermatol. 88, 70–73 (1963)
M. Aqil, A. Ali, Y. Sultana, A.K. Najmi, Fabrication and evaluation of polymeric films for transdermal delivery of pinacidil. Pharmazie 59, 631–635 (2004)
D.A. Dimas, P.P. Dallas, D.M. Rekkas, N.H. Choulis, Effect of several factors on the mechanical properties of pressure-sensitive adhesives used in transdermal therapeutic systems. AAPS PharmSciTech. 1(2), E16 (2000)
K. Sudeji, M. Kawasaki, H. Inada, K. Kattayama, M. Kakemi, T. Koizumi, Enhanced percutaneous absorption of fomoterol fumarate via pulsed iontophoresis. I. Effects of constant current and constant voltage. Yakugaku Zasshi 109, 766–770 (1989)
Y. Merino, A. Lopez, Y.N. Kalia, R.H. Guy, Electrorepulsion versus electroosmosis: effect of pH on the iontophoretic flux of 5-fluorouracil. Pharm. Res. 16, 758–761 (1999)
A.R. Denet, R. Vanbever, V. Preat, Skin electroporation for transdermal and topical delivery. Adv. Drug Deliv. Rev. 56, 659–674 (2004)
A.C. Hirsch, R.S. Upasani, A.K. Banga, Factorial design approach to evaluate interactions between electrically assisted enhancement and skin stripping for delivery of tacrine. J. Control Release 103, 113–121 (2005)
Y. Fumiyoshi, K. Yasuo, K. Megumi, T. Yoshinobu, H. Mitsuru, Analysis of in vivo skin penetration enhancement by oleic acid based on a two-layer diffusion model with polar and nonpolar routes in the stratum corneum. Int. J. Pharm. 117, 173–179 (1995)
Acknowledgments
This work was supported by Indian Council of Medical Research (ICMR), Govt. of India, IRIS Cell No. 2005-00760. The authors acknowledge to all research colleagues. Mr. Raghavendra (National Process Automation, Bangalore, India), Mr. Nagraja (Indian Space Research Organization, Bangalore) and Mrs. Manjula (Indian Institute of Science, Bangalore) are thankfully acknowledged for their support in research work.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Chandrashekar, N.S., Shobha Rani, R.H. Microprocessor in controlled transdermal drug delivery of anti-cancer drugs. J Mater Sci: Mater Med 20 (Suppl 1), 189–194 (2009). https://doi.org/10.1007/s10856-008-3510-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10856-008-3510-6